Kanta Marwah Research Innovation Fund

Established in early 2025, the KMRIF supports high-impact research that addresses critical unmet needs for people living with Parkinson’s and helps accelerate promising discoveries from the lab bench to the clinic.The Fund is designed to be flexible and responsive, supporting innovative projects that advance new therapeutic approaches, improve early detection, and strengthen the tools needed to better predict and treat Parkinson’s disease. Below are the projects supported through the KMRIF to date.

2025 projects:

Dr. Christopher Pack – McGill University, Montreal Neurological Institute 

Alleviating Parkinsonian symptoms with non-invasive brain stimulation 

Dr. Shady Rahayel – Université de Montréal, Centre d’études avancées en médecine du sommeil 

Validation of a deformation-based MRI signature for predicting phenoconversion in isolated REM sleep behaviour disorder (iRBD) 

Dr. Michael Schlossmacher – University of Ottawa, Ottawa Hospital Research Institute 

Adding smell testing to C-OPN’s inventory: Filling a void to better predict incident Parkinson’s disease 

Previously funded: 

Dr. Lorraine Kalia – University of Toronto, University Health Network 

Blood-brain barrier-crossing peptides for the treatment of Parkinson’s disease